Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 8, p. 1258, doi. 10.1093/ndt/gfae016
- By:
- Publication type:
- Article
Works by Gengshi Chen
Results: 4
1
2
Immunomodulatory roles of selenium nanoparticles: Novel arts for potential immunotherapy strategy development.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.956181
- By:
- Publication type:
- Article
3
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia.
- Published in:
- BMC Nephrology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12882-022-03054-5
- By:
- Publication type:
- Article
4
Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden.
- Published in:
- 2022
- By:
- Publication type:
- journal article